Moody Lynn & Lieberson LLC Has $15.84 Million Position in Johnson & Johnson (JNJ)

Moody Lynn & Lieberson LLC cut its position in shares of Johnson & Johnson (NYSE:JNJ) by 4.7% during the 3rd quarter, Holdings Channel reports. The firm owned 121,821 shares of the company’s stock after selling 6,029 shares during the quarter. Johnson & Johnson makes up approximately 1.9% of Moody Lynn & Lieberson LLC’s holdings, making the stock its 16th largest holding. Moody Lynn & Lieberson LLC’s holdings in Johnson & Johnson were worth $15,838,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. OLD Point Trust & Financial Services N A boosted its holdings in Johnson & Johnson by 2.2% during the second quarter. OLD Point Trust & Financial Services N A now owns 61,326 shares of the company’s stock worth $8,113,000 after purchasing an additional 1,321 shares during the last quarter. Eagle Ridge Investment Management boosted its stake in Johnson & Johnson by 3.5% in the third quarter. Eagle Ridge Investment Management now owns 27,522 shares of the company’s stock valued at $3,578,000 after acquiring an additional 928 shares during the last quarter. Welch & Forbes LLC boosted its stake in Johnson & Johnson by 0.9% in the second quarter. Welch & Forbes LLC now owns 718,331 shares of the company’s stock valued at $95,028,000 after acquiring an additional 6,730 shares during the last quarter. Janney Montgomery Scott LLC boosted its stake in Johnson & Johnson by 0.5% in the second quarter. Janney Montgomery Scott LLC now owns 771,868 shares of the company’s stock valued at $102,110,000 after acquiring an additional 3,533 shares during the last quarter. Finally, Oliver Luxxe Assets LLC boosted its stake in Johnson & Johnson by 12.7% in the second quarter. Oliver Luxxe Assets LLC now owns 17,538 shares of the company’s stock valued at $2,320,000 after acquiring an additional 1,972 shares during the last quarter. Institutional investors and hedge funds own 65.70% of the company’s stock.

A number of research analysts have weighed in on JNJ shares. Vetr upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $152.28 target price on the stock in a research note on Tuesday, January 23rd. Credit Suisse Group set a $154.00 target price on shares of Johnson & Johnson and gave the company an “outperform” rating in a research note on Thursday, October 19th. Royal Bank of Canada boosted their target price on shares of Johnson & Johnson from $144.00 to $147.00 and gave the company an “outperform” rating in a research note on Wednesday, October 18th. Stifel Nicolaus boosted their target price on shares of Johnson & Johnson from $142.00 to $145.00 and gave the company a “hold” rating in a research note on Wednesday, January 24th. Finally, Citigroup boosted their target price on shares of Johnson & Johnson from $140.00 to $149.00 and gave the company a “buy” rating in a research note on Monday, October 23rd. Four analysts have rated the stock with a sell rating, eight have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. Johnson & Johnson currently has an average rating of “Hold” and a consensus target price of $146.16.

Shares of Johnson & Johnson (JNJ) opened at $129.53 on Friday. The company has a market cap of $356,710.00, a P/E ratio of 332.13, a P/E/G ratio of 2.37 and a beta of 0.74. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.02 and a current ratio of 1.32. Johnson & Johnson has a 52 week low of $114.23 and a 52 week high of $148.32.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings results on Tuesday, January 23rd. The company reported $1.74 EPS for the quarter, beating the Zacks’ consensus estimate of $1.72 by $0.02. The company had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.08 billion. Johnson & Johnson had a net margin of 1.70% and a return on equity of 27.80%. Johnson & Johnson’s revenue was up 11.5% compared to the same quarter last year. During the same period in the prior year, the company posted $1.58 EPS. research analysts predict that Johnson & Johnson will post 8.08 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Tuesday, February 27th will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.59%. The ex-dividend date is Monday, February 26th. Johnson & Johnson’s payout ratio is currently 861.54%.

TRADEMARK VIOLATION NOTICE: This piece of content was first reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece of content on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.com-unik.info/2018/02/10/moody-lynn-lieberson-llc-has-15-84-million-position-in-johnson-johnson-jnj.html.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit